Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
Next >
Altimmune says weight loss drug minimized muscle loss in trial results that may set it apart
March 27, 2024
Tags
Health & Science
Health care industry
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
March 27, 2024
Tags
Companies
Science
Health & Science
From
CNBC.com News
Viking Therapeutics stock jumps 15% on promising weight loss pill data
March 26, 2024
Tags
Health & Science
Viking Therapeutics Inc
Pharmaceuticals
From
CNBC.com News
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
March 24, 2024
Tags
Science
Companies
Health care industry
From
CNBC.com News
Two fresh ways to play the weight loss and megacap tech hype
March 23, 2024
Tags
NVIDIA Corp
Investment strategy
Artificial intelligence
From
CNBC.com News
Here's how much people are willing to spend on weight loss drugs, according to a new survey
March 23, 2024
Tags
Companies
Health care industry
Novo Nordisk A/S
From
CNBC.com News
Cramer's Lighting Round: Arm is a buy
March 22, 2024
Tags
Business News
Investment strategy
S&P 500
From
CNBC.com News
Medicare can now cover certain weight loss drugs in a big step for patients
March 21, 2024
Tags
Eli Lilly and Co
Biotech and Pharmaceuticals
Business
From
CNBC.com News
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
March 19, 2024
Tags
Health care industry
Novo Nordisk A/S
Madrigal Pharmaceuticals Inc
From
CNBC.com News
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
March 16, 2024
Tags
Health care industry
Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
March 14, 2024
Tags
Business News
Biotechnology
US: News
From
CNBC.com News
Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
March 14, 2024
Tags
Health & Science
Novo Nordisk A/S
Pharmaceuticals
From
CNBC.com News
Experts hesitate on weight loss ETFs amid the obesity drug boom
March 13, 2024
Tags
Obesity
Eli Lilly and Co
Markets
From
CNBC.com News
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
March 13, 2024
Tags
Amazon/com Inc
Breaking news
Companies
From
CNBC.com News
Jim Cramer reviews Citi's European 'Super Seven'
March 08, 2024
Tags
U/S/ Markets
Novo Nordisk A/S
Stock Picks
From
CNBC.com News
Novo Nordisk's Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage
March 08, 2024
Tags
Business News
Breaking News: Business
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
March 08, 2024
Tags
Biotech and Pharmaceuticals
Business
Companies
From
CNBC.com News
Novo Nordisk market cap surpasses Tesla on new obesity pill trial data
March 08, 2024
Tags
Tesla Inc
Biotech and Pharmaceuticals
Europe Markets
From
CNBC.com News
Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
March 07, 2024
Tags
Investment strategy
Breaking News: Investing
Investing
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
March 05, 2024
Tags
Science
Companies
Breaking news
From
CNBC.com News
Cramer says get ready to buy if there's a market sell-off: 'I have my shopping list'
March 04, 2024
Tags
Stock Picks
Novo Nordisk A/S
U/S/ Markets
From
CNBC.com News
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
March 03, 2024
Tags
Biotech and Pharmaceuticals
Business
Eli Lilly and Co
From
CNBC.com News
Europe is having its worst earnings season since the onset of Covid — with little hope of a quick turnaround
March 01, 2024
Tags
Politics
Deutsche Bank AG
Economic events
From
CNBC.com News
5 things to know before the stock market opens Thursday
February 29, 2024
Tags
Paramount Global
Earnings
Novo Nordisk A/S
From
CNBC.com News
CNBC Daily Open: Markets brace for Fed's key inflation gauge
February 29, 2024
Tags
Europe Markets
Market Outlook
Eli Lilly and Co
From
CNBC.com News
CNBC Daily Open: Wall Street on edge over Fed's key inflation gauge
February 28, 2024
Tags
Reliance Steel & Aluminum Co
Economic events
Asia Markets
From
CNBC.com News
The big health decisions Americans will need to make after starting new weight loss drugs
February 28, 2024
Tags
Diet and exercise
Diets and dieting
Obesity
From
CNBC.com News
The pet drugs vets are now prescribing look a lot more like human medications
February 28, 2024
Tickers
CATS
DOGS
PETS
Tags
AstraZeneca PLC
Health Insurance
Zoetis Inc
From
CNBC.com News
Healthy Returns: The newest treatment use for weight loss drugs? Liver disease
February 27, 2024
Tags
Healthy Returns
Health & Science
Zealand Pharma A/S
From
CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
February 27, 2024
Tags
Nestle SA
Goldman Sachs Group Inc
Breaking News: Investing
From
CNBC.com News
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.